Status:
NOT_YET_RECRUITING
Relationship Between Oxytocin Level, Trust, and Attachment in Individuals With Borderline Personality Disorder
Lead Sponsor:
State University of New York - Upstate Medical University
Conditions:
Borderline Personality Disorder
Eligibility:
All Genders
18+ years
Brief Summary
We aim to assess the baseline oxytocin levels in individuals with borderline personality disorder and correlate those levels with social behavior, and compare the results with controls. Primary Hypot...
Eligibility Criteria
Inclusion
- Individuals with borderline personality disorder will qualify as cases
- controls will be age, gender matched individuals without any psychiatric/mental health concerns
Exclusion
- for all: pregnancy, hormonal or neurological disorders, and any kind of regular medication
- additional exclusion criteria for cases: a lifetime diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or significant neurological disease, current alcohol/ drug dependence
- for controls: MacLEan screening instrument for BPD will be used at the time of screening to exclude BPD diagnosis in controls
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT06045650
Start Date
June 1 2024
End Date
September 1 2025
Last Update
May 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SUNY Upstate Medical University
Syracuse, New York, United States, 13210